Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors

Bioconjugate Chemistry

Volumn 20, Issue 8, 2009, Pages 1602-1610

  Alshoukr, Faisal ^a,b,c   Rosant, Cedric ^a,b,c   Maes, Veronique ^d   Abdelhak, Jallane ^a,b,c   Raguin, Olivier ^a,b,c   Burg, Samuel ^a,b,c   Sarda, Laure ^a,b,c   Barbet, Jacques ^c,e   Tourwé, Dirk ^d   Pelaprat, Didier ^a,b,c   Gruaz Guyon, Anne ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CNRS   (France)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^e UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DIAGNOSIS; DISEASES; MEDICAL IMAGING; PEPTIDES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SYNTHESIS (CHEMICAL);

BREAST CANCER CELLS; CANCER CELLS; FURTHER DEVELOPMENT; IN-VIVO; NEUROTENSIN; PANCREATIC ADENOCARCINOMA; PEPTIDE SEQUENCES; RADIOLABELLING; RADIOLIGANDS; TUMOR SELECTIVITIES;

TUMORS;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ARGININE; CHELATING AGENT; ISOLEUCINE; LUTETIUM 177; LYSINE; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR; PENTETATE INDIUM IN 111; PROLINE; RADIOISOTOPE; RADIOLIGAND; RHENIUM; TECHNETIUM; TYROSINE; YTTRIUM 90;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BREAST CANCER; CONTROLLED STUDY; ENZYME DEGRADATION; FEMALE; HUMAN; HUMAN CELL; INTESTINE; ISOTOPE LABELING; LIVER; MOLECULE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ACTIVITY RELATION; TUMOR;

ANIMALIA;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; INDIUM RADIOISOTOPES; LIGANDS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; NEUROTENSIN; PANCREATIC NEOPLASMS; PENTETIC ACID; RECEPTORS, NEUROTENSIN; TISSUE DISTRIBUTION;

EID: 70349133991     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900151z     Document Type: Article

References (43)

1. Parsons, C. M., Sutcliffe, J. L., and Bold, R. J. (2008) Preoperative evaluation of pancreatic adenocarcinoma. J. Hepatobil. Pancreat. Surg. 15, 429-435.
2. Reubi, J. C., Waser, B., Friess, H., Buchler, M., and Laissue, J. (1998) Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut 42, 546-550. (Pubitemid 28186573)
3. Ehlers, R. A., Kim, S., Zhang, Y., Ethridge, R. T., Murrilo, C., Hellmich, M. R., Evans, D. B., Townsend, C. M., Jr., and Mark Evers, B. (2000) Gut peptide receptor expression in human pancreatic cancers. Ann. Surg. 231, 838-848.
4. Reubi, J. C., Waser, B., Schaer, J. C., and Laissue, J. A. (1999) Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas. Int. J. Cancer 82, 213-218. (Pubitemid 29293780)
5. Bossard, C., Souaze, F., Jarry, A., Bezieau, S., Mosnier, J. F., Forgez, P., and Laboisse, C. L. (2007) Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis. Peptides 28, 2030-2035. (Pubitemid 47419096)
6. Pelosi, G., Volante, M., Papotti, M., Sonzogni, A., Masullo, M., and Viale, G. (2006) Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy. Q. J. Nucl. Med. Mol. Imaging 50, 272-287. (Pubitemid 46157609)
7. Souaze, F., Dupouy, S., Viardot-Foucault, V., Bruyneel, E., Attoub, S., Gespach, C., Gompel, A., and Forgez, P. (2006) Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression. Cancer Res. 66, 6243-6249.
8. Granier, C., van Rietschoten, J., Kitabgi, P., Poustis, C., and Freychet, P. (1982) Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetylneurotensin-(8-13) is the shortest analogue with full binding and pharmacological activities. Eur. J. Biochem. 124, 117-124.
9. Garcia-Garayoa, E., Allemann-Tannahill, L., Blauenstein, P., Willmann, M., Carrel-Remy, N., Tourwe, D., Iterbeke, K., Conrath, P., and Schubiger, P. A. (2001) In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors. Nucl. Med. Biol. 28, 75-84. (Pubitemid 32155967)
10. Bruehlmeier, M., Garayoa, E. G., Blanc, A., Holzer, B., Gergely, S., Tourwe, D., Schubiger, P. A., and Blauenstein, P. (2002) Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding. Nucl. Med. Biol. 29, 321-327. (Pubitemid 34258554)
11. Buchegger, F., Bonvin, F., Kosinski, M., Schaffland, A. O., Prior, J., Reubi, J. C., Blauenstein, P., Tourwe, D., Garcia Garayoa, E., and Bischof Delaloye, A. (2003) Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients. J. Nucl. Med. 44, 1649-1654.
12. Garcia-Garayoa, E., Blauenstein, P., Blanc, A., Maes, V., Tourwe, D., and Schubiger, P. A. (2009) A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours. Eur. J. Nucl. Med. Mol. Imaging 36, 37-47.
13. Maes, V., Garcia-Garayoa, E., Blauenstein, P., and Tourwe, D. (2006) Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties. J. Med. Chem. 49, 1833-1836. (Pubitemid 43376527)
14. Maina, T., Nikolopoulou, A., Stathopoulou, E., Galanis, A. S., Cordopatis, P., and Nock, B. A. (2007) [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results. Eur. J. Nucl. Med. Mol. Imaging 34, 1804-1814. (Pubitemid 47599059)
15. Garcia-Garayoa, E., Maes, V., Blauenstein, P., Blanc, A., Hohn, A., Tourwe, D., and Schubiger, P. A. (2006) Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors. Nucl. Med. Biol. 33, 495-503. (Pubitemid 43729857)
16. Moerlein, S. M., Daugherty, A., Sobel, B. E., and Welch, M. J. (1991) Metabolic imaging with gallium-68 and indium-111-labeled low-density lipoprotein. J. Nucl. Med. 32, 300-307.
17. Wagner, S. J., and Welch, M. J. (1979) Gallium-68 labeling of albumin and albumin microspheres. J. Nucl. Med. 20, 428-433.
18. Fani, M., Andre, J. P., and Maecke, H. R. (2008) 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contr. Med. Mol. Imaging 3, 67-77. (Pubitemid 351722193)
19. Liu, S. (2008) Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv. Drug. Delivery Rev. 60, 1347-1370.
20. Achilefu, S., Srinivasan, A., Schmidt, M. A., Jimenez, H. N., Bugaj, J. E., and Erion, J. L. (2003) Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors. J. Med. Chem. 46, 3403-3411. (Pubitemid 36842424)
21. de Visser, M., Janssen, P. J., Srinivasan, A., Reubi, J. C., Waser, B., Erion, J. L., Schmidt, M. A., Krenning, E. P., and de Jong, M. (2003) Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. Eur. J. Nucl. Med. Mol. Imaging 30, 1134-1139. (Pubitemid 36988225)
22. Hillairet De Boisferon, M., Raguin, O., Thiercelin, C., Dussaillant, M., Rostene, W., Barbet, J., Pelegrin, A., and Gruaz-Guyon, A. (2002) Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model. Bioconjugate Chem. 13, 654-662. (Pubitemid 34527529)
23. Bergmann, R., Scheunemann, M., Heichert, C., Mading, P., Wittrisch, H., Kretzschmar, M., Rodig, H., Tourwe, D., Iterbeke, K., Chavatte, K., Zips, D., Reubi, J. C., and Johannsen, B. (2002) Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs. Nucl. Med. Biol. 29, 61-72. (Pubitemid 34092305)
24. Achilefu, S., Wilhelm, R. R., Jimenez, H. N., Schmidt, M. A., and Srinivasan, A. (2000) A new method for the synthesis of tri-tert-butyl diethylenetriaminepentaacetic acid and its derivatives. J. Org. Chem. 65, 1562-1565. (Pubitemid 30145994)
25. Janevik-Ivanovska, E., Gautherot, E., Hillairet de Boisferon, M., Cohen, M., Milhaud, G., Tartar, A., Rostene, W., Barbet, J., and Gruaz-Guyon, A. (1997) Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy. Bioconjugate Chem. 8, 526-533. (Pubitemid 27347560)
26. Raguin, O., Fournie-Zaluski, M. C., Romieu, A., Pelegrin, A., Chatelet, F., Pelaprat, D., Barbet, J., Roques, B. P., and Gruaz-Guyon, A. (2005) A labeled neutral endopeptidase inhibitor as a potential tool for tumor diagnosis and prognosis. Angew. Chem., Int. Ed. Engl. 44, 4058-4061. (Pubitemid 40886447)
27. Raguin, O., Gruaz-Guyon, A., and Barbet, J. (2002) Equilibrium expert: an add-in to Microsoft Excel for multiple binding equilibrium simulations and parameter estimations. Anal. Biochem. 310, 1-14. (Pubitemid 35387325)
28. 111In-DTPA-conjugated peptides. Nucl. Med. Biol. 28, 761-768.
29. Froidevaux, S., Calame-Christe, M., Tanner, H., and Eberle, A. N. (2005) Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake. J. Nucl. Med. 46, 887-895. (Pubitemid 43750768)
30. Vita, N., Laurent, P., Lefort, S., Chalon, P., Dumont, X., Kaghad, M., Gully, D., Le Fur, G., Ferrara, P., and Caput, D. (1993) Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett. 317, 139-142. (Pubitemid 23043957)
31. Kitabgi, P. (2006) Functional domains of the subtype 1 neurotensin receptor (NTS1). Peptides 27, 2461-2468.
32. Melis, M., Krenning, E. P., Bernard, B. F., de Visser, M., Rolleman, E., and de Jong, M. (2007) Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences. Nucl. Med. Biol. 34, 633-641. (Pubitemid 47248283)
33. Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., and Virgolini, I. J. (2007) 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J. Nucl. Med. 48, 508-518. (Pubitemid 47571404)
34. 111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol. Imaging Biol. 5, 42-48.
35. de Visser, M., Verwijnen, S. M., and de Jong, M. (2008) Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy. Cancer Biother. Radiopharm. 23, 137-157.
36. 177 Lu-DOTA 0, Tyr3]octreotate: toxicity, efficacy, and survival. J. Clin. Oncol. 26, 2124-2130.
37. Krenning, E. P., Teunissen, J. J., Valkema, R., deHerder, W. W., deJong, M., and Kwekkeboom, D. J. (2005) Molecular radiotherapy with somatostatin analogs for neuro-endocrine tumors. J. Endocrinol. Invest. 28, 146-150.
38. Maecke, H. R., Hofmann, M., and Haberkorn, U. (2005) (68)Ga-labeled peptides in tumor imaging. J. Nucl. Med. 46 (Suppl 1), 172S-178S.
39. Schubiger, P. A., Allemann-Tannahill, L., Egli, A., Schibli, R., Alberto, R., Carrel-Remy, N., Willmann, M., Blauenstein, P., and Tourwe, D. (1999) Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides. Q. J. Nucl. Med. 43, 155-158. (Pubitemid 29318050)
40. Mier, W., Zitzmann, S., Kramer, S., Reed, J., Knapp, E. M., Altmann, A., Eisenhut, M., and Haberkorn, U. (2007) Influence of chelate conjugation on a newly identified tumor-targeting peptide. J. Nucl. Med. 48, 1545-1552. (Pubitemid 47397405)
41. 3 bombesin analogues. Nucl. Med. Biol. 34, 17-28.
42. de Jong, M., Rolleman, E. J., Bernard, B. F., Visser, T. J., Bakker, W. H., Breeman, W. A., and Krenning, E. P. (1996) Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. J. Nucl. Med. 37, 1388-1392.
43. Vegt, E., van Eerd, J. E., Eek, A., Oyen, W. J., Wetzels, J. F., de Jong, M., Russel, F. G., Masereeuw, R., Gotthardt, M., and Boerman, O. C. (2008) Reducing renal uptake of radiolabeled peptides using albumin fragments. J. Nucl. Med. 49, 1506-1511.